newsfilter
← Latest News
Business Wire·

Pathos AI Completes Acquisition of Rain Oncology

Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights Pathos AI, Inc. ("Pathos") today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. ("Merger Sub"),